Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 131

    1.

    Template for toxicants: gene expression varies by cell type.

    Barrett JR.

    Environ Health Perspect. 2004 Nov;112(16):A944. No abstract available. PMID: 15598609 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prediction of toxicant-specific gene expression signatures after chemotherapeutic treatment of breast cell lines.

    Troester MA, Hoadley KA, Parker JS, Perou CM.

    Environ Health Perspect. 2004 Nov;112(16):1607-13.PMID: 15598611 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    In vitro breast cancer cell lethality of Brazilian plant extracts.

    Suffredini IB, Paciencia ML, Frana SA, Varella AD, Younes RN.

    Pharmazie. 2007 Oct;62(10):798-800.PMID: 18236788 [PubMed - indexed for MEDLINE]Related articles

    4.

    Uncertain identity of doxorubicin-resistant MCF-7 cell lines expressing mutated p53.

    Pirnia F, Breuleux M, Schneider E, Hochmeister M, Bates SE, Marti A, Hotz MA, Betticher DC, Borner MM.

    J Natl Cancer Inst. 2000 Sep 20;92(18):1535-6. No abstract available. PMID: 10995814 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Collagen gel droplet-embedded culture drug sensitivity test in human breast cancer]

    Yamamoto Y, Watanabe Y, Ishida N, Hidaka T, Sugishita H, Yoshida M, Yukumi S, Sato K, Nakagawa H, Horiuchi A, Kawachi K.

    Gan To Kagaku Ryoho. 2008 May;35(5):793-6. Japanese. PMID: 18487915 [PubMed - indexed for MEDLINE]Related articles

    7.

    [The influence of Survivin in drug resistance of breast cancer cell]

    Xie P, Ruan QR, Li JC.

    Zhonghua Bing Li Xue Za Zhi. 2005 Jun;34(6):367-8. Chinese. No abstract available. PMID: 16185509 [PubMed - indexed for MEDLINE]Related articles

    8.

    Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells.

    Du J, Shi Y, Pan Y, Jin X, Liu C, Liu N, Han Q, Lu Y, Qiao T, Fan D.

    Cancer Biol Ther. 2005 Feb;4(2):242-7. Epub 2005 Feb 20.PMID: 15846068 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.

    Villeneuve DJ, Hembruff SL, Veitch Z, Cecchetto M, Dew WA, Parissenti AM.

    Breast Cancer Res Treat. 2006 Mar;96(1):17-39. Epub 2005 Dec 2.PMID: 16322897 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cytotoxins and cancer immunotherapy: the dance of the macabre?

    Allegra CJ, Childs RW.

    J Natl Cancer Inst. 2005 Oct 5;97(19):1396-7. No abstract available. PMID: 16204684 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes.

    Calcagno AM, Fostel JM, To KK, Salcido CD, Martin SE, Chewning KJ, Wu CP, Varticovski L, Bates SE, Caplen NJ, Ambudkar SV.

    Br J Cancer. 2008 May 6;98(9):1515-24. Epub 2008 Apr 1.PMID: 18382425 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells.

    Mallory JC, Crudden G, Oliva A, Saunders C, Stromberg A, Craven RJ.

    Mol Pharmacol. 2005 Dec;68(6):1747-56. Epub 2005 Sep 8.PMID: 16150928 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.

    Györffy B, Serra V, Jürchott K, Abdul-Ghani R, Garber M, Stein U, Petersen I, Lage H, Dietel M, Schäfer R.

    Oncogene. 2005 Nov 17;24(51):7542-51.PMID: 16044152 [PubMed - indexed for MEDLINE]Related articles

    14.

    S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.

    He Z, Gao J, Wang Q, Liu M, Li Y, Li X, Tang H, Zheng J.

    Oncol Rep. 2008 Aug;20(2):325-32.PMID: 18636193 [PubMed - indexed for MEDLINE]Related articles

    16.

    Progestin inhibition of cell death in human breast cancer cell lines.

    Moore MR, Spence JB, Kiningham KK, Dillon JL.

    J Steroid Biochem Mol Biol. 2006 Mar;98(4-5):218-27. Epub 2006 Feb 8.PMID: 16466914 [PubMed - indexed for MEDLINE]Related articles

    17.

    Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells.

    Bar-On O, Shapira M, Hershko DD.

    Anticancer Drugs. 2007 Nov;18(10):1113-21.PMID: 17893511 [PubMed - indexed for MEDLINE]Related articles

    18.

    Drug resistance in chemotherapy for breast cancer.

    Saeki T, Tsuruo T, Sato W, Nishikawsa K.

    Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:84-9.PMID: 16273361 [PubMed - indexed for MEDLINE]Related articles

    19.

    Breast cancer gene microarrays pass muster.

    Twombly R.

    J Natl Cancer Inst. 2006 Oct 18;98(20):1438-40. No abstract available. PMID: 17047189 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells.

    Singh S, Chhipa RR, Vijayakumar MV, Bhat MK.

    Cancer Lett. 2006 May 18;236(2):213-21. Epub 2005 Jul 5.PMID: 15996812 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data